Kirby M J, Turner P
Arch Int Pharmacodyn Ther. 1977 Jan;225(1):25-8.
Fenfluramine in therapeutic concentrations causes a significant and dose related increase in glucose uptake into isolated rat and human skeletal muscle in the presence of insulin. Using fenfluramine, 100 ng/ml, on the rat hemidiaphragm preparation the effects of the following receptor blocking drugs in concentrations up to 250 ng/ml were investigated on this phenomenon: atropine, haloperidol, mepyramine, methysergide, propranolol and thymoxamine. Only methysergide, the 5-HT antagonist, reduced the action of fenfluramine in relatively low concentrations of the drug which were dose related (10 ng/ml causing approximately 40% inhibition). This suggests that the peripheral as well as the central actions of fenfluramine are mediated through 5-HT receptors.
在胰岛素存在的情况下,治疗浓度的芬氟拉明会使分离出的大鼠和人类骨骼肌对葡萄糖的摄取显著增加,且呈剂量相关。在大鼠半横膈膜标本上使用100纳克/毫升的芬氟拉明,研究了浓度高达250纳克/毫升的以下受体阻断药物对这一现象的影响:阿托品、氟哌啶醇、甲氧苄二胺、麦角新碱、普萘洛尔和噻吗心安。只有5-羟色胺拮抗剂麦角新碱在相对低浓度药物(剂量相关,10纳克/毫升引起约40%的抑制)时能降低芬氟拉明的作用。这表明芬氟拉明的外周和中枢作用均通过5-羟色胺受体介导。